New York-based Pfizer Inc. (PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. Valued at a market cap of $139.5 billion, the company operates in three segments: Biopharma, PC1, and Pfizer Ignite. PFE is expected to release its Q2 2026 earnings on Tuesday, Aug. 4, before the market opens.
Ahead of the event, analysts expect the company’s EPS to be $0.68 on a diluted basis, down 12.8% from $0.78 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in all of its last four quarters.